ArticleThe Journal of clinical endocrinology and metabolism2024

Anamorelin: Ghrelin Receptor Agonism as a Potential Intervention for Osteosarcopenia.

Palak Patadia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.